Literature DB >> 1790753

Points of action in the campaign against blindness in developing countries.

J S Stilma1, S Franken, M Hogeweg, P Hardus.   

Abstract

This article provides a survey of the problems of prevention of blindness in developing countries. The World Health Organization estimates that 31 million people are blind and 15 million people partially-sighted. The main cause of blindness is cataract. Other causes are trachoma, glaucoma, xerophthalmia, river blindness, corneal scars and leprosy. Prevention or treatment of these causes is possible in more than 80% of cases. The number of blind persons, however, is still increasing due to the increase in population and the immense shortage of all kinds of ophthalmological equipment and personnel. An effective strategy for the prevention of blindness in developing countries should focus on: more cheap cataract operations, increasing teaching facilities for ophthalmic personnel, integration of ophthalmic care into the general health system and the promotion of blindness prevention in political organizations.

Entities:  

Mesh:

Year:  1991        PMID: 1790753     DOI: 10.1007/bf00165693

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  56 in total

1.  Morphology of posterior segment lesions of the eye in patients with onchocerciasis.

Authors:  A C Bird; J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

2.  Ocular and systemic side effects following ivermectin treatment in onchocerciasis patients from Sierra Leone.

Authors:  J S Stilma; A Rothova; G van der Lelij; W R Wilson; R F Barbe
Journal:  Acta Leiden       Date:  1990

3.  Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus.

Authors:  K Y Dadzie; J Remme; E S Alley; G de Sole
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jan-Feb       Impact factor: 2.184

Review 4.  The World Health Organization's programme for the prevention of blindness.

Authors:  B Thylefors
Journal:  Int Ophthalmol       Date:  1990-05       Impact factor: 2.031

5.  Failure of filtration operations in the African.

Authors:  N H Welsh
Journal:  Br J Ophthalmol       Date:  1970-09       Impact factor: 4.638

6.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

7.  Side-effects of ivermectin in treatment of onchocerciasis.

Authors:  A Rothova; A van der Lelij; J S Stilma; W R Wilson; R F Barbe
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

8.  Clinical characteristics of vitamin A responsive and nonresponsive Bitot's spots.

Authors:  N Emran; S Tjakrasudjatma
Journal:  Am J Ophthalmol       Date:  1980-08       Impact factor: 5.258

9.  Increased mortality in children with mild vitamin A deficiency.

Authors:  A Sommer; I Tarwotjo; G Hussaini; D Susanto
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

10.  3.8 million blinded by cataract each year: projections from the first epidemiological study of incidence of cataract blindness in India.

Authors:  D C Minassian; V Mehra
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

View more
  2 in total

1.  Social economic development in the prevention of global blindness.

Authors:  V H Ho; I R Schwab
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  Cataract surgery at district hospital level.

Authors:  C van der Windt; H S Chana
Journal:  Int Ophthalmol       Date:  1993-10       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.